| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 07/18/2023 | BridgeBio Pharma, Inc. | BBIO | Sale | Common Stock | 1.5M | $35.00 | $52.5M | See Explanation of Responses | 07/18/2023 |
| 05/09/2023 | 4D Molecular Therapeutics, Inc. | FDMT | Purchase | Common Stock | 850k | $16.00 | $13.6M | See Explanation Responses | 05/09/2023 |
| 11/22/2022 | Frazier Lifesciences Acquisition Corp | | Conversion | Class A Ordinary Shares | 1.2M | $0.00 | $0 | See Explanation of Responses | 11/22/2022 |
| 11/22/2022 | Frazier Lifesciences Acquisition Corp | | Conversion | Class A Ordinary Shares | 2.5M | $0.00 | $0 | See Explanation of Responses | 11/22/2022 |
| 11/15/2022 | Rallybio Corp | RLYB | Purchase | Pre-Funded Warrants to Purchase Common Stock | 3.3M | $0.00 | $333.3 | See Explanation of Responses | 11/15/2022 |
| 11/11/2022 | Amylyx Pharmaceuticals, Inc. | | Conversion | Series C-1 Preferred Stock | 4.9M | $0.00 | $0 | See Explanation of Responses | 01/11/2022 |
| 10/07/2022 | Inhibrx, Inc. | INBX | Purchase | Common Stock | 1000k | $30.00 | $30M | See Explanation of Responses | 10/07/2022 |
| 10/07/2022 | Inhibrx, Inc. | INBX | Purchase | Common Stock | 333.3k | $30.00 | $10M | See Explanation of Responses | 10/07/2022 |
| 09/09/2022 | Amylyx Pharmaceuticals, Inc. | | Sale | Common Stock | 312.4k | $29.87 | $9.3M | See Explanation of Responses | 09/08/2022 |
| 09/09/2022 | Amylyx Pharmaceuticals, Inc. | | Sale | Common Stock | 156.5k | $30.90 | $4.8M | See Explanation of Responses | 09/08/2022 |
| 09/09/2022 | Amylyx Pharmaceuticals, Inc. | | Sale | Common Stock | 6.7k | $31.44 | $209.2k | See Explanation of Responses | 09/08/2022 |
| 09/09/2022 | Amylyx Pharmaceuticals, Inc. | | Sale | Common Stock | 147.5k | $29.87 | $4.4M | See Explanation of Responses | 09/08/2022 |
| 09/09/2022 | Amylyx Pharmaceuticals, Inc. | | Sale | Common Stock | 73.9k | $30.90 | $2.3M | See Explanation of Responses | 09/08/2022 |
| 09/09/2022 | Amylyx Pharmaceuticals, Inc. | | Sale | Common Stock | 3.1k | $31.44 | $98.8k | See Explanation of Responses | 09/08/2022 |
| 09/08/2022 | Amylyx Pharmaceuticals, Inc. | | Sale | Common Stock | 80.7k | $27.28 | $2.2M | See Explanation of Responses | 09/08/2022 |
| 09/08/2022 | Amylyx Pharmaceuticals, Inc. | | Sale | Common Stock | 108.6k | $28.16 | $3.1M | See Explanation of Responses | 09/08/2022 |
| 09/08/2022 | Amylyx Pharmaceuticals, Inc. | | Sale | Common Stock | 159k | $29.14 | $4.6M | See Explanation of Responses | 09/08/2022 |
| 09/08/2022 | Amylyx Pharmaceuticals, Inc. | | Sale | Common Stock | 16k | $30.59 | $489.3k | See Explanation of Responses | 09/08/2022 |
| 09/08/2022 | Amylyx Pharmaceuticals, Inc. | | Sale | Common Stock | 111.1k | $32.23 | $3.6M | See Explanation of Responses | 09/08/2022 |
| 09/08/2022 | Amylyx Pharmaceuticals, Inc. | | Sale | Common Stock | 38.1k | $27.28 | $1M | See Explanation of Responses | 09/08/2022 |
| 09/08/2022 | Amylyx Pharmaceuticals, Inc. | | Sale | Common Stock | 51.3k | $28.16 | $1.4M | See Explanation of Responses | 09/08/2022 |
| 09/08/2022 | Amylyx Pharmaceuticals, Inc. | | Sale | Common Stock | 75.1k | $29.14 | $2.2M | See Explanation of Responses | 09/08/2022 |
| 09/08/2022 | Amylyx Pharmaceuticals, Inc. | | Sale | Common Stock | 7.6k | $30.59 | $231.1k | See Explanation of Responses | 09/08/2022 |
| 09/08/2022 | Amylyx Pharmaceuticals, Inc. | | Sale | Common Stock | 52.5k | $32.23 | $1.7M | See Explanation of Responses | 09/08/2022 |
| 03/18/2022 | PROCEPT BioRobotics Corp | PRCT | Sale | Common Stock | 1.1M | $29.90 | $34.3M | See Explanation of Responses | 03/18/2022 |
| 03/18/2022 | PROCEPT BioRobotics Corp | PRCT | Sale | Common Stock | 101.8k | $29.90 | $3M | See Explanation of Responses | 03/18/2022 |
| 03/02/2022 | Ginkgo Bioworks Holdings, Inc. | | Other (acquisition) | Class C Common Stock | 288M | $0.00 | $0 | See Explanation of Responses | 03/02/2022 |
| 03/02/2022 | Ginkgo Bioworks Holdings, Inc. | | Other (disposition) | Class A Common Stock | 288M | $0.00 | $0 | See Explanation of Responses | 03/02/2022 |
| 01/11/2022 | Amylyx Pharmaceuticals, Inc. | | Conversion | Common Stock | 4.9M | $0.00 | $0 | See Explanation of Responses | 01/11/2022 |
| 01/11/2022 | Amylyx Pharmaceuticals, Inc. | | Purchase | Common Stock | 2.3M | $19.00 | $43.7M | See Explanation of Responses | 01/11/2022 |
| 01/03/2022 | APi Group Corp | APG | Purchase | 5.5% Series B Perpetual Convertible Preferred Stock | 196k | $24.60 | $4.8M | Held by Viking Global Equities Master Ltd. | 01/03/2022 |
| 01/03/2022 | APi Group Corp | APG | Purchase | 5.5% Series B Perpetual Convertible Preferred Stock | 4k | $24.60 | $98.4k | Held by Viking Global Equities II LP | 01/03/2022 |
| 09/17/2021 | PROCEPT BioRobotics Corp | PRCT | Conversion | Common Stock | 3.4M | $0.00 | $0 | See Explanation of Responses | 09/17/2021 |
| 09/17/2021 | PROCEPT BioRobotics Corp | PRCT | Conversion | Common Stock | 679k | $0.00 | $0 | See Explanation of Responses | 09/17/2021 |
| 09/17/2021 | PROCEPT BioRobotics Corp | PRCT | Conversion | Common Stock | 113.7k | $0.00 | $0 | See Explanation of Responses | 09/17/2021 |
|